Source: Health Canada shortage reports · Updated Jul 9, 2026
Buprenorphine Naloxone has no current shortage reported in Canada. It has been in shortage before; the history is below.
A combination medication used to treat opioid use disorder.
Products affected
0 / 11
Reports on file
29
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
8MG
2MG · TABLET · TEVA CANADA LIMITED
DIN 02453916 · ended Apr 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
2MG
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02453908 · ended Apr 8, 2026 · Disruption of the manufacture of the drug.
Resolved
SUBOXONE
0.5MG
2MG · TABLET · INDIVIOR UK LIMITED
DIN 02295695 · ended Mar 31, 2025 · Delay in product release
Resolved
PMS-BUPRENORPHINE-NALOXONE
0.5MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02424851 · ended Oct 4, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
2MG
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02453908 · ended Jun 26, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
2MG
8MG · TABLET · TEVA CANADA LIMITED
DIN 02453916 · ended Jun 26, 2024 · Disruption of the manufacture of the drug.
Resolved
SUBOXONE
1MG
4MG · FILM, SOLUBLE · INDIVIOR UK LIMITED
DIN 02502321 · ended Jul 4, 2023 · Demand increase for the drug.
Resolved
SUBOXONE
2MG
8MG · FILM, SOLUBLE · INDIVIOR UK LIMITED
DIN 02502348 · ended May 18, 2023 · Demand increase for the drug.
Resolved
SUBOXONE
0.5MG
2MG · FILM, SOLUBLE · INDIVIOR UK LIMITED
DIN 02502313 · ended Apr 28, 2023 · Demand increase for the drug.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
2MG
8MG · TABLET · TEVA CANADA LIMITED
DIN 02453916 · ended Dec 21, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-BUPRENORPHINE/NALOXONE
2MG
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02453908 · ended Dec 1, 2022 · Disruption of the manufacture of the drug.
Resolved
PMS-BUPRENORPHINE-NALOXONE
8MG
2MG · TABLET · PHARMASCIENCE INC
DIN 02424878 · ended Jan 16, 2022 · Delay in shipping of the drug.
Showing 12 of 29 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Buprenorphine Naloxone. Health Canada has 29 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Buprenorphine Naloxone is classified under “DRUGS USED IN ADDICTIVE DISORDERS” (ATC N07BC).
Recent changes
No changes recorded yet.
Common questions
What is Buprenorphine Naloxone used for?
A combination medication used to treat opioid use disorder.
When will Buprenorphine Naloxone be back in stock in Canada?
Buprenorphine Naloxone has no active shortage; supply is normal per Health Canada reports.
Why is Buprenorphine Naloxone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.